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Abstract 
BACKGROUND: The gene polymorphism (-308G/A) and tumor necrosis factor-alpha (TNF-α) levels influence 
development of disease in type 2 diabetic patients and tuberculosis patients.  
AIM: In this study, we analyze the association between the TNF-α polymorphisms (-308G/A) and the levels of 
TNF-α in type 2 diabetic patients with and without tuberculosis infection. 
METHODS: This study was an analytic observational with cross sectional approach consisting 40 type 2 diabetic 
patients with tuberculosis infection, 40 type 2 diabetic patients without tuberculosis infection and 40 healthy 
control (HC) subjects. The TNF-α gene polymorphism (-308G/A) was analyzed with polymerase chain reaction-
restriction fragment lengths polymorphisms (PCR-RFLP) method. The TNF-α levels were measured using an 
enzyme-linked immunosorbent assay. The association between gene polymorphism (-308G/A) in study groups 
was analyzed by Fisher's exact test, tumor necrosis factor-alpha (TNF-α) levels in study groups was carried out 
using the Kruskal-Wallis test. Hardy-Weinberg Equilibrium also determined genotype deviation and allele 
frequencies. 
RESULTS: The GG and GA+AA genotypes frequency in both of patient groups and HC subjects were not differ 
significantly (95% and 5% vs 95% and 5% vs 92.5% and 7.5%; p > 0.05). The TNF-α levels (pg/ml) of type 2 
diabetic without tuberculosis infection were higher than those of type 2 diabetic with tuberculosis infection and HC 
subjects (7.42 ± 0.78 vs 2.23 ± 0.51 vs 2.57 ± 0.63; p < 0.01). The TNF-α levels in the GA+AA genotypes were 
higher than the GG wild-type genotype (p > 0.05). There was no significant deviation of genotype frequency and 
allele from Hardy-Weinberg Equilibrium. 
CONCLUSION: The gene polymorphism (-308G/A) had no association with type 2 diabetic patients with and 
without tuberculosis infection and the gene polymorphism (-308G/A) was not influence the TNF-α levels but there 
was a significant differentiation of TNF-α levels between the groups. 
 
 
 
Introduction 
 
Diabetes mellitus (DM) is the disorder of 
metabolic pathway caused by the failure of the 
function and or production of insulin which increase 
blood glucose levels (BGLs) or hyperglycemia 
[1].According to the data of International Diabetes 
Federation (IDF) in 2015, Indonesia ranked as the 
seventh highest number of diabetic patients worldwide 
with 10 millions case [2]. In 2013, The Indonesia 
Ministry of Health stated there was approximately 205 
thousand diabetic patients in North Sumatra. Hence, 
North Sumatra got 8
th
 rank in terms of the number of 
diabetic patients in Indonesia [3].  
Several evidences showed DM increases the 
risk of respiratory disease. World Health Organization 
(WHO) showed that DM will increase the risk of 
tuberculosis infection two to three times higher than 
healthy population [4]. The relationship of DM with 
tuberculosis infection was reported for the first time by 
Avicenna (Ibnu Sina) in XI century. Ibnu Sina reported 
that the tuberculosis infection is the main cause of 
death in diabetic patients. In postmortem autoption, 
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more than 50% diabetic patients had tuberculosis 
infection. Mycobacterium tuberculosis (Mtb) is the only 
cause of an infectious disease called tuberculosis. 
The bacteria were found by Robert Koch in 1882 [5]. 
The incident of TB were 10.4 million cases in 2016 
and the TB mortality rate (per 100 000 population) fell 
by 37% between 2000 and 2016 year [6]. 
In DM, hyperglycemia leads a disorder of the 
immune system as the risk factor for activation of 
latent tuberculosis infection, or appearance of 
tuberculosis primer infection [7]. These would be 
resulting in disruption of proinflammatory cytokine 
production. Recently, experts suggest the metabolic 
disorders and infectious diseases were associated 
with interferon gamma, interleukin (IL)-6, IL-10, tumor 
necrosis factor (TNF)-α, etc [8], [9], [10]. 
TNF-α is a proinflammatory cytokine that 
synthesized by macrophages. The synthesis of TNF-
αis regulated by specific TNF-α gene sequences. 
Single nucleotide polymorphism (SNPs) or 
substitution of one nucleotide base in the TNF-α gene 
influence the synthesis or levels of TNF-α [11]. 
Previous studies showedthere was an associationof 
TNF-α gene polymorphism (-308G/A) with diabetes 
incidence. Another studies showed allele A of the 
TNF-α gene at position (-308G/A) associated with risk 
for tuberculosis but those results were still conflicting 
[12], [13], [14], [15], [16], [17]. 
Previous studies also showed there was 
relationship of TNF-α gene polymorphism with TNF-α 
levels in diabetic patients and relationship of TNF-α 
gene polymorphism with TNF-α levels in tuberculosis 
patients but there was no study assessed the 
relationship of TNF-α gene polymorphisms (-308G/A) 
and TNF-α levels in type 2 diabetic patients with 
tuberculosis infection and without tuberculosis 
infection [12], [13], [14], [15], [16], [17]. Therefore, we 
investigated the association of TNF-α polymorphisms 
(-308G/A) and TNF-α levels in Type 2 Diabetic 
Patients with TB infection and without TB infection in 
this study. 
 
 
Methods 
 
Ethics 
The research was conducted after got an 
approval from the Medical Ethics Committee 
Universitas Sumatera Utara (No.227KOMET/FK 
USU/2018). The study was conducted from March 
until June 2018. 
 
Subjects 
This study was an analytic observational with 
cross sectional approach consisting 40 type 2 diabetic 
patients with tuberculosis infection, 40 type 2 diabetic 
patients without tuberculosis infection and 40 healthy 
control (HC) subjects. Type 2 diabetic patients with 
tuberculosis infection were recruited at the health care 
facilities for pulmonary disease (BP4) Medan city. 
Type 2 diabetic patients without tuberculosis were 
recruited at Padang Bulan primary health care in 
Medan city. The HC subjects were recruited at a gym 
place in Medan city. The match samples with inclusion 
and exclusion criterias were selected according to 
researcher’s decision. Eligible patients had no taking 
drugs that affect the levels of TNF-α proinflammatory 
cytokines such as anti-inflammatory drugs and 
antibiotics at least 2 days before blood collection, 
willing to be a study participant and signed informed 
consent. Patient who consumed vitamin supplements, 
had immune deficiencies such as HIV, had organ 
transplant, kidney function disorders, liver function 
disorders, malignancies, pregnancy and lactation, 
extra pulmonary tuberculosis were excluded from this 
study. 
The eligible HC subject had age and sex 
matched with patient groups, healthy, selected based 
on interviews using questionnaires, blood tests routine 
and blood glucose levels (BGLs), willing to be a 
research subject and signed informed consent. The 
HC subject who had family history of DM were 
excluded from this study. 
 
Subjects and sample preparation 
Demographic characteristics of subject were 
obtained by filling out questionnaire form. 
Measurements of BGLs, TNF-α levels and analysis of 
TNF-α gene polymorphism (-308G/A) were done at 
the Integrated Laboratory of the Faculty of Medicine, 
Universitas Sumatera Utara (USU). The study took 
place from March to July 2018. Five ml of blood 
samples were withdrawn from the mediana cubiti vein, 
put into ice box and delivered to the Integrated 
Laboratory of Faculty of Medicine, Universitas 
Sumatera Utara. All the blood samples were 
centrifuged in 10 minutes at 3000 rpm then serum 
was separated, and stored in refrigerator at -80°C for 
measurement of TNF-α levels. BGLs was measured 
within 2 hours after being taken. DNA was isolated 
from blood leukocytes by usinggenomic DNA kit 
commercial based on manual prosedur kit (Promega, 
USA). DNAisolate was then stored at temperature -
80°C for determination of gene polymorphism. 
 
Determination of gene polymorphism (-
 308G/A) 
The amplification of isolated DNA was 
performed withthe polymerase chain reaction (PCR) 
technique [18]. The amplified products were observed 
on agarose gel at 107 bp. The PCR reaction mixture 
(10 µl) was digested using restriction fragment length 
polymorphism (RFLP) techniqueby the 5 U of 
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restriction NcoI enzyme and incubated at 37°C for 2 
hours, [19]. The PCR-RFLP products were 
electrophoresed in a 4% agarose gel. 
 
The measurement of biomarkers levels 
BGLs (mg/dl) were measured using 
commercial glucose kit (Bt. Diagnostic) and read with 
a spectrophotometer at a wavelength of 500 nm. TNF-
α levels were measured using commercial TNF-α kit 
(Biolegend kit) with enzyme linked immunosorbent 
assay (ELISA) method. The result could be read by 
the ELISA raider (pg/ml) at 450 nm within 30 minutes 
with a sensitivity of 3.5 pg/ml and specificity up to 50 
ng/ml. 
 
Statistical Analysis 
Data were analyzed using statistical package 
for social sciences (SPSS v.22) software. Association 
between gene polymorphism (-308G/A) in study 
groups was analyzed by Fisher's exact test, whereas 
Hardy-Weinberg equilibrium (HWE) was analyzed by 
the Chi-Square test. Comparison mean of blood 
glucose levels (BGLs) and tumor necrosis factor-alpha 
(TNF-α) levels in study groups was carried outusing 
the Kruskal-Wallis test and followed by Mann-Whitney 
test for post hoc comparison test with the significance 
level (< 0.05). The differences of the TNF-α levels on 
genotype variants in this population study was 
checked by the Kruskal Wallis test. 
 
 
Results 
 
The polymerase chain reaction (PCR) 
products of TNF-α gene had done visualized on 2% 
agarose gel and all samples detected had TNF-α 
gene at 107 bp. Digestion of PCR product of TNF-α 
gene by the Nco1 enzyme shown 3 bands at 107 bp, 
87 bp dan 20 bp. 
The distribution of TNF-α gene polymorphism 
(-308G/A) in groups of subjects can be seen in Table 
1. 
Table 1: Frequency of genotypes within the (-308G/A) region of 
TNF-α gene at each groups 
Genotype  
Type 2 diabetic patients 
with TB (N = 40) 
Type 2 diabetic patients 
without TB (N = 40) 
HC (N = 40) p 
GG 38 (95%) 38 (95%) 37 (92.5%) 
0.864 
GA+AA 2 (5%) 2 (5%) 3 (7.5%) 
TB = Tuberculosis infection; HC = Healthy control. 
 
Frequency of GG and GA+AA genotypes in 
both of patient groups were not much different with 
healthy subjects (95% and 5% vs 95% and 5% vs 
92.5% and 7.5%; p > 0.05). In this study, the 
comparison of mean BGLs and TNF-α levels between 
type 2 diabetic patients with and without tuberculosis 
infection and healthy control (HC) can be seen in 
Table 2. 
Table 2: Comparison of BGLs and TNF-α levels in type 2 
diabetic patients with and without tuberculosis infection and 
healthy subjects 
Biochemical 
T2 diabetic 
patients with TB 
(N = 40) 
T2 diabetic 
patients without 
TB (N = 40) 
HC (N = 40) p 
Glucose (mg/dl) 295.13
a 
(± 57.16) 246.15
b 
(± 73.30) 104.73 (± 19.29) 0.01 
TNF-α (pg/ml) 2.23
c 
(± 0.51) 7.42
d 
(± 0.78) 2.57 (± 0.63) 0.01 
TB = Tuberculosis infection; HC = Healthy control; Data shown as mean ± standard 
deviation; Mann-Whitney test for post-hoc comparison; 
a
 p = 0.01 vs HC;
 b
 p = 0.01 vs HC; 
a, b
 p = 0.01; 
c
 p = 0.46 vs HC;
 d
 p = 0.01 vs HC; 
c, d
 p = 0.01. 
 
The mean of BGLs in type 2 diabetic patients 
with tuberculosis infection was higher (295.13
a 
(± 
57.16) mg/dl) as compared to type 2 diabetic without 
tuberculosis infection and HC (246.15
b 
(± 73.30) and 
104.73 (± 19.29) mg/dl) with p < 0.05. Post hoc 
comparison between each groups were statistically 
significant (p < 0.05). The mean of TNF-α levels in 
type 2 diabetic patients without tuberculosis infection 
was higher as compared to type 2 diabetic with 
tuberculosis infection and HC (p < 0.05). Mann-
Whitney test for post hoc comparison was shown 
association between type 2 diabetic without 
tuberculosis infection and type 2 diabetic with 
tuberculosis infection (p < 0.05), also in type 2 diabetic 
without tuberculosis infection and HC (p < 0.05) but no 
association in type 2 diabetic with tuberculosis 
infection with HC (p > 0.05). 
The association of genotypes of TNF-α gene 
polymorphism (-308G/A) with TNF-α levels shows in 
Table 3. 
Table 3: The TNF-α levels in subjects with variant genotypes of 
TNF-α gene polymorphism (-308G/A) 
Biomarker 
Subjects (N = 120) 
p 
GG (N = 113) GA+AA (N = 7) 
TNF-α (pg/ml) 3.98 (± 0.36) 5.58 (± 0.33) 0.43 
 
The TNF-α levels were higher in GA+AA 
mutant genotypes compared in GG wild-type 
genotype but the association between genotypes of 
TNF-α gene and TNF-α levels shows no significant 
difference performed by Kruskal Wallis test (p > 0.05). 
 
 
Discussion 
 
In this present study, we analyzed the TNF-α 
gene from all samples in type 2 diabetic patients with 
and without tuberculosis infection groups and healthy 
control group. The TNF-α gene was detected at 107 
bp and polymorphism (-308G/A) showed three type of 
genotypes, namely GG, GA and AA. Hardy-Weinberg 
Equilibrium was done analysis in all groups and the 
results were consistent with the HWE (p > 0.05), it 
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means the relative proportions of genotype in the 
three groups were constant from one generation to 
the next. The genotype in this population still in 
equilibrium is due to the possibility of random 
marriage, and no migration to the population [20]. 
Several mutations and polymorphisms have been 
described for TNF-α gene. The TNF-α gene is located 
on chromosome 6 (6p21.3) between HLA-B and DR, 
in the class III region at the Major Histocompatibility 
Complex (MHC) [11]. The gene polymorphism (-
308G/A) is located in the promoter region of the gene 
and involves in the substitution of a guanine (G) by an 
adenine (A) of the TNF-α gene sequence. 
Polymorphism is a change of nucleotide sequences in 
genes that result in variations in protein function. 
Polymorphism can determine susceptibility to disease. 
The impact of polymorphism is a change in the 
vulnerability of a population to illness [21]. Our result 
showed the TNF-α gene polymorphism (-308G/A) had 
no significant difference between type 2 diabetic 
patients with and without tuberculosis infection and 
HC subjects. Previous study showed there was an 
association of gene polymorphism (-308G/A) with DM 
[14], [22]. Another study showed that A allele of TNF-α 
at position (-308) was associated with tuberculosis 
infection [12]. Wu et al., (2017) notice that TNF-α 
gene polymorphism (-308G/A) was associated with 
severity of tuberculosis infection in a Chinese Han 
Population [23]. In this context, previous study 
showed that the GG wild type genotype significantly 
decreased in diabetic patients and also in tuberculosis 
patients compared to healthy subjects, different with 
our study that found the GG genotype frequency was 
highest in all groups. Study by Jamil et al., reported 
that TNF-α −308G/A polymorphism was a potent risk 
factor for diabetes in higher age (> 45) groups [24]. 
We also analyzed association between TNF-α 
levels in type 2 diabetic patients with and without 
tuberculosis infection and healthy control group. We 
found that TNF-α levels in type 2 diabetic patients 
without tuberculosis infection was higher compared to 
type 2 diabetic patients with tuberculosis infection and 
healthy control subjects. Previous study byde Souza 
Bastos et al., showed the increasing levels of TNF-α 
in uncontrolled and controlled of diabetic patients 
compared to the healthy subjects [25]. Another 
previous study also showed that there was an 
association of TNF-α levels, blood glucose levels and 
HbA1c in type 2 diabetic patients [26]. Study by de 
Andrade Junior et al., showed that the increasing 
levels of TNF-α related to the severity and 
complications in tuberculosis infection [27]. In 
tuberculosis infection, disruption of immune system of 
the body carried out by Mtb. The body's defences 
against Mtb is the secretion of TNF-α. The cytokine 
will enhance the ability of phagocytosis of 
macrophages and induce macrophage apoptosis 
infected with these Mtb [9]. 
TNF-α is a type of proinflammatory cytokine 
which also has role as mediator in inflammatory 
reaction. The action of TNF-α as an inﬂammatory 
cytokine via induction of other cytokines such as IL-1 
and IL-6 [11], [21]. In DM, the inflammation process 
was induced by increasing of glucose oxidation in 
hyperglycemia condition [28]. Hyperglycemia 
correlated with increase reactive oxygen species 
(ROS) and lipid peroxides such as malondialdehyde 
(MDA) [24], [29]. The process continues to decrease 
antioxidants levels. Previous study showed that there 
was a decrease of glutathione peroxidase and 
glutathione in DM patients compared to healthy 
subjects [30]. The other study showed that decrease 
of SOD level occurred in tuberculosis patients with 
DM compared to healthy subjects [31]. Decline of 
antioxidants levels stimulate oxidative stress in the 
cell and trigger insulin resistance. Several studies 
showed that insulin resistance was associated with 
the production of TNF-α [32], [33].
 
Our study did not find association between 
gene polymorphism (-308G/A) and TNF-α levels in 
study groups. Previous studies also showed that there 
was no an asscoiation between TNF- gene 
polymorphism (-308G/A) and TNF- levels in type 2 
diabetic patients [7]. Our result was contradictive with 
study by Joshi et al., which showed an 
associationbetween genotypes TNF- gene 
polymorphism (-308G/A) and TNF- levels in 
tuberculosis patients [9]. The TNF- levels can be 
affected by many factors. The unmodifiable or 
irreversible factor in nature was genetic profiles. Gene 
polymorphism as genetic profile referred to the 
individual characteristics was affected by ethnicity. 
The modifiable or reversible factor (environmental) 
were nutrition intake, lifestyle, etc [20], [34]. The 
limitation of this study was nutrition intake, lifestyle of 
patients group and healthy subjects did not assessed. 
The TNF-α levels in this population could be affected 
by an environmental factor due there was no 
association between TNF-α gene polymorphism (-
308G/A) and TNF- level in patients group and 
healthy control subject. 
In conclusion, there was no association of 
gene polymorphism (-308G/A) with type 2 diabetic 
patients with and without tuberculosis infection but the 
TNF-α levels showed the different result. The 
genotypes distribution of gene polymorphism (-
308G/A) were not affect the TNF- levels in this 
population study. Further study should be conducted 
to analyse the environmental factors on the research 
subjects. 
 
 
Acknowledgement 
 
The authors are grateful to all the participants 
for close cooperation in this study. 
Basic Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
3964                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
References 
 
1. Powers AC. Diabetes mellitus, In: Harrison's principles of internal 
medicine. Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, 
Jameson JL, Loscalzo J. Eds. 17th edition. McGraw-Hill, New York, 
2008:2275-2279. 
2. International Diabetic Federation. IDF Diabetic Atlas. Chapter 3, 8 edition, 
2017:19, 43-46.  
3. World Health Organization. Collaborative framework for care and control 
of tuberculosis and diabetes. World Health Organization; 2011.  
4. Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan 
Republik Indonesia 2013. RISET KESEHATAN DASAR Jakarta. Hal, 
2013:87. 
 
5. Smith I. Mycobacterium tuberculosis pathogenesis and molecular 
determinants of virulence. Clin Microbiol Rev. 2003; 16(3):463-96. 
https://doi.org/10.1128/CMR.16.3.463-496.2003 PMid:12857778 
PMCid:PMC164219 
 
6. World Health Organization. Global Tuberculosis Report, 2017. avalaible 
at:http://www.who.int/tb/  
7. Baghaei P, Marjani M, Javanmard P, Tabarsi P, Masjedi MR. Diabetes 
mellitus and tuberculosis facts and controversies. J Diabetes Metab Disord. 
2013; 20:12(1):58. https://doi.org/10.1186/2251-6581-12-58 PMid:24360398 
PMCid:PMC3922915 
 
8. Rodrigues KF, Pietrani NT, Bosco AA, Campos FMF, Sandrim VC, Gomes 
KB. IL-6, TNF-α, and IL-10 levels/polymorphisms and their association with 
type 2 diabetes mellitus and obesity in Brazilian individuals. Arch Endocrinol 
Metab. 2017; 61. https://doi.org/10.1590/2359-3997000000254 
PMid:28225860 
 
9. Lin PL, Plessner HL, Voitenok NN, Flynn JL. Tumor necrosis factor and 
tuberculosis. J Investig Dermatology Symp Proc. 2007; 12(1):22-5. 
https://doi.org/10.1038/sj.jidsymp.5650027 PMid:17502865 
 
10. Joshi L, Ponnana M, Sivangala R, et al. Evaluation of TNF-α, IL-10 and 
IL-6 Cytokine Production and Their Correlation with Genotype Variants 
amongst Tuberculosis Patients and Their Household Contacts. PLoS One. 
2015; 10(9):e0137727. https://doi.org/10.1371/journal.pone.0137727 
PMid:26359865 PMCid:PMC4567353 
 
11. Fiers W. Tumor necrosis factor Characterization at the molecular, cellular 
and in vivo level. FEBS Lett. 1991; 285(2):199-212. 
https://doi.org/10.1016/0014-5793(91)80803-B 
 
12. Shahsavar F, Varzi1 A M, Azargoon A. Association between TNF -
308G/A polymorphism and susceptibility to pulmonary tuberculosis in the Lur 
population of Iran. Asian Pac J Trop Biomed. 2016; 6(1):80-83. 
https://doi.org/10.1016/j.apjtb.2015.09.017 
 
13. Merza M, Farnia P, Anoosheh S, Varahram M, Kazampour M, Pajand O, 
Saeif S, Mirsaeidi M, Masjedi MR, Velayati AA and Hoffner H. The NRAMPI, 
VDR and TNF-α Gene Polymorphisms in Iranian Tuberculosis Patients: The 
Study on Host Susceptibility. The Brazilian Journal of Infectious Diseases. 
2009; 13(4):252-256. https://doi.org/10.1590/S1413-86702009000400002 
PMid:20231985 
 
14. Golshani H, Haghani K, Dousti M, Bakhtiyari S. Association of TNF-α 
308 G/A Polymorphism With Type 2 Diabetes: A Case-Control Study in the 
Iranian Kurdish Ethnic Group. Osong Public Health Res Perspect. 2015; 
6(2):94-9. https://doi.org/10.1016/j.phrp.2015.01.003 PMid:25938018 
PMCid:PMC4411339 
 
15. Feng RN, Zhao C, Sun CH and Li Y. Meta-analysis of TNF 308 G/A 
polymorphism and type 2 diabetes mellitus. PLoS One. 2011; 6:e18480. 
https://doi.org/10.1371/journal.pone.0018480 PMid:21494616 
PMCid:PMC3072982 
 
16. Luna GI, Cristina I, Sanchez MN. Association between -308G / A TNFA 
Polymorphism and Susceptibility to Type 2 Diabetes Mellitus : A Systematic 
Review. J Diabetes Investig. 2016; 2016:1-6. 
https://doi.org/10.1155/2016/6309484 PMid:27822481 PMCid:PMC5086378 
 
17. Yi YX, Han JB, Zhao L, Fang Y, Zhang YF, Zhou GY. Tumor necrosis 
factor alpha gene polymorphism contributes to pulmonary tuberculosis 
susceptibility: evidence from a meta-analysis. Int J Clin Exp Med. 2015; 
8(11):20690-700. 
 
18. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base 
polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene 
detectable by NcoI restriction of PCR product. Hum. Mol. Genet. 1992; 
 
1(5):353. https://doi.org/10.1093/hmg/1.5.353 PMid:1363876 
19. Ceylan E, Karkucak M, Coban H, Karadag M, Yakut T. Evaluation of 
TNF-alpha gene (G308A) and MBL2 gene codon 54 polymorphisms in 
Turkish patients with tuberculosis. J Infect Public Health. 2017; 10(6):774-7. 
https://doi.org/10.1016/j.jiph.2016.11.003 PMid:28189510 
 
20. Andrews CA. The Hardy-Weinbreg Principle. Nature Edu Knowledge. 
2010; 3(10):65.  
21. Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarret-Nedwin J, 
Pennica D, Goeddel DV, Gray PW. Human lymphotoxin and tumor necrosis 
factor genes: structure, homology and chromosomal localization. Nucleic 
Acids Res. 1985; 13:6361-6373. https://doi.org/10.1093/nar/13.17.6361 
PMid:2995927 PMCid:PMC321958 
 
22. Zhao Y, Li Z, Zhang L, Zhang Y, Yang Y, Tang Y, Fu P. The TNF-alpha -
308G/A polymorphism is associated with type 2 diabetes mellitus: an 
updated meta-analysis. Molecular Biology Reports. 2014; 42(1):73-83. 
https://doi.org/10.1007/s11033-013-2839-1 PMid:24197696 
 
23. Wu S, Wang Y, Zhang M, Shrestha SS, Wang M, He J. Genetic 
Polymorphisms of IL1B, IL6, and TNFα in a Chinese Han Population with 
Pulmonary Tuberculosis. BioMed Research International. 2018; 2018. 
https://doi.org/10.1155/2018/3010898 PMid:29888256 PMCid:PMC5977055 
 
24. Jamil K, Jayaraman A,Ahmad J, Joshi S, Yerra SK.TNF-alpha −308G/A 
and −238G/A polymorphisms and its protein network associated with type 2 
diabetes mellitus. Saudi Journal of Biological Sciences. 2017; 24(6):1195-
1203. https://doi.org/10.1016/j.sjbs.2016.05.012 PMid:28855812 
PMCid:PMC5562469 
 
25. de Souza Bastos A, Graves DT, de Melo Loureiro AP, Júnior CR, Corbi 
SCT, Frizzera F, et al. Diabetes and increased lipid peroxidation are 
associated with systemic inflammation even in well-controlled patients. J 
Diabetes Complications. 2016; 30(8):1593-9. 
https://doi.org/10.1016/j.jdiacomp.2016.07.011 PMid:27497685 
PMCid:PMC5120401 
 
26. Mirza S, Hossain M, Mathews C, Martinez P, Sc M, Fisher-hoch SP. 
Type 2 Diabetes is Associated with Elevated Levels of TNF-alpha, IL-6, and 
Adiponectin and Low Levels of Leptin in a Population of Mexican American: 
A Cross-Sectional Study. Cytokine. 2012; 57(1):136-42. 
https://doi.org/10.1016/j.cyto.2011.09.029 PMid:22035595 
PMCid:PMC3270578 
 
27. de Andrade Júnior DR, dos Santos SA, de Castro I, de Andrade DR. 
Correlation between serum tumor necrosis factor alpha levels and clinical 
severity of tuberculosis. Braz J Infect Dis. 2008; 12(3):226-33. 
https://doi.org/10.1590/S1413-86702008000300013 PMid:18833408 
 
28. Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and 
type 2 diabetes mellitus. World J Diabetes. 2015; 6(3):456-80. 
https://doi.org/10.4239/wjd.v6.i3.456 PMid:25897356 PMCid:PMC4398902 
 
29. Sari MI, Ilyas S, Widyawati T, Antika MA. Effect of lawsonia innermis 
(linn) leaves ethanolic extract on blood glucose and malondialdehyde level in 
alloxan-induced diabetic rats. IOP Conf Ser Earth Environ Sci. 2018; 130(1). 
https://doi.org/10.1088/1755-1315/130/1/012034 
 
30. Sari MI, Tala ZZ, Wahyuni DD. Association between Glycated 
Hemoglobin with the Levels of Serum proinflammatory Cytokines and 
Antioxidants in Patients with Type 2 Diabetes Mellitus in Universitas 
Sumatera Utara Hospital. Open Access Macedonian Journal of Medical 
Sciences. 2019; 7(5):715-20. https://doi.org/10.3889/oamjms.2019.168 
PMid:30962826 PMCid:PMC6447341 
 
31. Sari MI, Daulay M, Wahyuni DD. Superoxide Dismutase Levels and 
Polymorphism (Ala16val) in Tuberculosis Patients with Diabetes Mellitus in 
Medan City. Open Access Macedonian Journal of Medical Sciences. 2019; 
7(5):730-73. https://doi.org/10.3889/oamjms.2019.195 PMid:30962829 
PMCid:PMC6447346 
 
32. Akash MSH, Rehman K, Liaqat A. Tumor Necrosis Factor-Alpha: Role in 
Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes 
Mellitus. J Cell Biochem. 2017; 119(1):1-5. https://doi.org/10.1002/jcb.26174 
PMid:28569437 
 
33. Swaroop JJ, Rajarajeswari D, Naidu JN. Association of TNF-α with 
insulin resistance in type 2 diabetes mellitus. Indian J Med Res. 2012; 
135(1):127-30. https://doi.org/10.4103/0971-5916.93435 PMid:22382194 
PMCid:PMC3307173 
 
34. Nadeem A, Mumtaz S, Naveed AK. Inter-ethnic variations in association 
of TNF-alpha G308A single nucleotide polymorphism with type 2 diabetes 
mellitus-a review. J Diabetes Metab Disord Control. 2017; 4(2):48-53. 
https://doi.org/10.15406/jdmdc.2017.04.00105 
 
 
 
